Book a Meeting

BetterBet™ Anti-EGFR Half-Life Extended Antibody (CAT#: AES-0622-ZP1001) Datasheet

Target
EGFR
Description
Creative Biolabs enhances the binding ability of the anti-EGFR antibody to FcRn by modifying the Fc of the antibody, thereby increasing the half-life of the anti- antibody.
Applications
Increase the half-life of antibodies
Technology
Fc engineering technology

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced EGFR antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
epidermal growth factor receptor
Background
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog
Description
Creative Biolabs enhances the binding ability of the anti-EGFR antibody to FcRn by modifying the Fc of the antibody, thereby increasing the half-life of the anti- antibody.

The Fc of the antibody is engineered to enhance the binding ability of the antibody to FcRn, thereby increasing the half-life of the antibody

Related Products

Highly Galactosylated Anti-EGFR (Futuximab) Antibody (CAT#: BioBet-GA-205ZP)
Non-fucosylated Anti-Human EGFR (Panitumumab) Therapeutic Antibody (CAT#: BioBet-198ZP)
Highly Galactosylated Anti-EGFR (Matuzumab) Antibody (CAT#: BioBet-GA-201ZP)
Non-fucosylated Anti-Human EGFR (Matuzumab) Therapeutic Antibody (CAT#: BioBet-201ZP)
Highly Galactosylated Anti-EGFR (Necitumumab) Antibody (CAT#: BioBet-GA-009ZP)
Non-fucosylated Anti-Human EGFR (Cetuximab) Therapeutic Antibody (CAT#: BioBet-197ZP)
Non-fucosylated Anti-Human EGFR (Necitumumab) Therapeutic Antibody (CAT#: BioBet-009ZP)
Non-fucosylated Anti-Human EGFR (Futuximab) Therapeutic Antibody (CAT#: BioBet-205ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany